Small cap biotech investing

a: Investing in a Small Cap Biotech ~
b: Playing roulette with a rigged wheel

What: This Seattle Times story is a great piece of investigative journalism. The story was written in 2005 and is probably relevant today. The fact that Hedge Funds have paid doctors to discuss their work is something anyone contemplating this type of investment should consider. According to the story, which is very credible, hedge funds have paid doctors to discuss the results of the drug they are working on. These exclusive investors got info, before the company, before the regulatory agencies and before retail investors. As noted, these small biotech usually have 1 drug in the clinic, so information on that drug can significantly move the stock price up or down. These types of exchanges are totally slimy, typically violate NDAs and put individual investors at a severe disadvantage.

Writer: LucretiaGermanica
Date: May 22 2010 1:44 AM

No critique for this page.
Feel free to be the first

Please review the linked page for context.
If you can think of something better than this,
please add it to the database

(email or url) optional

This is an anti-spam device. Are you Human?

If so, please click the circle next to 'Yes' to submit your comment